Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Colestid
2. Colestipol
3. Colestipol Hcl
4. Hcl, Colestipol
5. Hydrochloride, Colestipol
6. U 26,597 A
7. U-26,597 A
8. U26,597 A
1. Colestid
2. Cholestabyl
3. 37296-80-3
4. Colestipol Hydrochloride [usan:usp]
5. Lestid
6. Flavored Colestid
7. N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;hydrochloride
8. U-26597a
9. Unii-x7d10k905g
10. Tetraethylenepentamine Hcl
11. Copolymer Of Diethylenetriamine And 1-chloro-2,3-epoxypropane, Hydrochloride (with Approximately 1 Out Of 5 Amine Nitrogens Protonated)
12. Schembl284758
13. Dtxsid40190737
14. X7d10k905g
15. Ft-0749664
Molecular Weight | 225.76 g/mol |
---|---|
Molecular Formula | C8H24ClN5 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 225.1720235 g/mol |
Monoisotopic Mass | 225.1720235 g/mol |
Topological Polar Surface Area | 88.1 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 78.6 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Colestipol hydrochloride |
Drug Label | COLESTID Granules and FLAVORED COLESTID Granules contain colestipol hydrochloride, which is a lipid lowering agent for oral use. Colestipol hydrochloride is an insoluble, high molecular weight basic anion-exchange copolymer of diethylenetriamine and... |
Active Ingredient | Colestipol hydrochloride |
Dosage Form | Tablet; Granule |
Route | Oral |
Strength | 1gm; 5gm/scoopful; 5gm/packet |
Market Status | Prescription |
Company | Impax Labs |
2 of 4 | |
---|---|
Drug Name | Flavored colestid |
Drug Label | COLESTID Granules and FLAVORED COLESTID Granules contain colestipol hydrochloride, which is a lipid lowering agent for oral use. Colestipol hydrochloride is an insoluble, high molecular weight basic anion-exchange copolymer of diethylenetriamine and... |
Active Ingredient | Colestipol hydrochloride |
Dosage Form | Granule |
Route | Oral |
Strength | 5gm/scoopful; 5gm/packet |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
3 of 4 | |
---|---|
Drug Name | Colestipol hydrochloride |
Drug Label | COLESTID Granules and FLAVORED COLESTID Granules contain colestipol hydrochloride, which is a lipid lowering agent for oral use. Colestipol hydrochloride is an insoluble, high molecular weight basic anion-exchange copolymer of diethylenetriamine and... |
Active Ingredient | Colestipol hydrochloride |
Dosage Form | Tablet; Granule |
Route | Oral |
Strength | 1gm; 5gm/scoopful; 5gm/packet |
Market Status | Prescription |
Company | Impax Labs |
4 of 4 | |
---|---|
Drug Name | Flavored colestid |
Drug Label | COLESTID Granules and FLAVORED COLESTID Granules contain colestipol hydrochloride, which is a lipid lowering agent for oral use. Colestipol hydrochloride is an insoluble, high molecular weight basic anion-exchange copolymer of diethylenetriamine and... |
Active Ingredient | Colestipol hydrochloride |
Dosage Form | Granule |
Route | Oral |
Strength | 5gm/scoopful; 5gm/packet |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
Anion Exchange Resins
High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions. (See all compounds classified as Anion Exchange Resins.)
Hypolipidemic Agents
Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)
Sequestering Agents
Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent. (See all compounds classified as Sequestering Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Colestipol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Colestipol, including repackagers and relabelers. The FDA regulates Colestipol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Colestipol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Colestipol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Colestipol supplier is an individual or a company that provides Colestipol active pharmaceutical ingredient (API) or Colestipol finished formulations upon request. The Colestipol suppliers may include Colestipol API manufacturers, exporters, distributors and traders.
click here to find a list of Colestipol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Colestipol DMF (Drug Master File) is a document detailing the whole manufacturing process of Colestipol active pharmaceutical ingredient (API) in detail. Different forms of Colestipol DMFs exist exist since differing nations have different regulations, such as Colestipol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Colestipol DMF submitted to regulatory agencies in the US is known as a USDMF. Colestipol USDMF includes data on Colestipol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Colestipol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Colestipol suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Colestipol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Colestipol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Colestipol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Colestipol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Colestipol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Colestipol suppliers with NDC on PharmaCompass.
Colestipol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Colestipol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Colestipol GMP manufacturer or Colestipol GMP API supplier for your needs.
A Colestipol CoA (Certificate of Analysis) is a formal document that attests to Colestipol's compliance with Colestipol specifications and serves as a tool for batch-level quality control.
Colestipol CoA mostly includes findings from lab analyses of a specific batch. For each Colestipol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Colestipol may be tested according to a variety of international standards, such as European Pharmacopoeia (Colestipol EP), Colestipol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Colestipol USP).
LOOKING FOR A SUPPLIER?